Calibration and normalization method for biosensors

Details for Australian Patent Application No. 2008233214 (hide)

Owner Novartis AG SRU Biosystems, Inc.

Inventors Li, Peter Y.; Gangadhar, Jogikalmath; Binder, Brant; Neuschafer, Dieter; Borsody, Alex; Budach, Wolfgang Ernst Gustav; Cunningham, Brian T.; Schulz, Stephen C.; Laing, Lange G.

Agent Spruson & Ferguson

Pub. Number AU-B-2008233214

PCT Pub. Number WO2008/121250

Priority 60/921,001 30.03.07 US; 60/998,880 11.10.07 US

Parent 2006279060

Filing date 21 March 2008

Wipo publication date 9 October 2008

Acceptance publication date 16 December 2010

International Classifications

G01N 33/48 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

C12Q 1/00 (2006.01) Measuring or testing processes involving enzymes or micro-organisms

G01N 21/55 (2006.01) Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible, or ultra-violet light - Specular reflectivity

G01N 21/64 (2006.01) Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible, or ultra-violet light - Fluorescence

Event Publications

13 August 2009 PCT application entered the National Phase

  PCT publication WO2008/121250 Priority application(s): WO2008/121250

16 December 2010 Application Accepted

  Published as AU-B-2008233214

14 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008233220-Adaptor for sample vial

2008233202-Alpha-2-delta ligand to treat lower urinary tract symptoms